In most cases, the tumor can be medically treated with mTOR inhibitors, which can prevent disease progression in children >3 years of age and has also been shown to be effective terms of cognition, development, and seizure control in TSC children [34,35,36]. Here, MTOR is linked to tuberous sclerosis.